Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL296 Target Snapshot

Gamma-aminobutyric acid receptor subunit gamma-1 · SINGLE PROTEIN · Rattus norvegicus

24Compounds
22Assays
1Approved Drugs
16.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P23574. Use UniProt P23574 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P23574 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Gamma-aminobutyric acid receptor subunit gamma-1 as ChEMBL target CHEMBL296, mapped to UniProt P23574. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Gamma-aminobutyric acid receptor subunit gamma-1
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL296
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P23574
Gamma-aminobutyric acid receptor subunit gamma-1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Gamma-aminobutyric acid receptor subunit gamma-1 is the right protein anchor across sources, using UniProt P23574 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGamma-aminobutyric acid receptor subunit gamma-1
UniProt AccessionP23574
Component TypeProtein
Sequence Length465 aa

Gamma-aminobutyric acid receptor subunit gamma-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Gamma-aminobutyric acid receptor subunit gamma-1, mapped to UniProt P23574. Sequence length is 465 aa.

Mapped IDP23574
Review nameGamma-aminobutyric acid receptor subunit gamma-1
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase I
Assay Mix

Activity Type Distribution

IC5015.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL42464 8.4 IC50 4.0 Preclinical
CHEMBL12 8.3 IC50 5.0 Approved
CHEMBL273481 8.22 IC50 6.0 Preclinical
CHEMBL10450 7.6 IC50 25.0 Preclinical
CHEMBL96 7.48 IC50 33.0 Preclinical
CHEMBL10438 7.4 IC50 40.0 Preclinical
CHEMBL38835 7.14 Kd 72.2 Preclinical
CHEMBL40804 6.6 IC50 250.0 Preclinical
CHEMBL296263 6.4 IC50 400.0 Preclinical
CHEMBL3138293 5.8 IC50 1600.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
1
5.5
1
6.0
1
6.5
3
7.0
1
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DIAZEPAM
CHEMBL12
Approved 1963
Assay Landscape

Assay Landscape

22
Total Assays
8
Tested Compounds
2
Assay Types
Binding — 13 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 6 2 5.6
cell membrane format 3 6 7.1
single protein format 3 0
tissue-based format 1 0
Functional — 9 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 3 3 6.5
tissue-based format 3 2 7.5
cell-based format 2 0
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine